Cancer and the microbiota
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
A host’s microbiota may increase, diminish, or have no effect at all on cancer susceptibility. Assigning causal roles in cancer to specific microbes and microbiotas, unraveling host-microbiota interactions with environmental factors in carcinogenesis, and exploiting such knowledge for cancer diagnosis and treatment are areas of intensive interest. This Review considers how microbes and the microbiota may amplify or mitigate carcinogenesis, responsiveness to cancer therapeutics, and cancer-associated complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss of microbial diversity (dysbiosis) is associated with chronic health conditions (26–28) and cancer (8–10), and is also associated with poor outcomes to certain forms of cancer therapy including allogeneic stem cell transplant (29).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“It has recently emerged that factors beyond tumor genomics influence cancer development and therapeutic responses (4–7), including host factors such as the gastrointestinal (gut) microbiome (8–10).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“their gene count that exceeds the human genome’s gene count by ~100-fold and enables diverse metabolic programming”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“the number of microbes that inhabit the human body (roughly equal to the number of human cells)”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“their effects on host immune system development and activity, including antitumor immunosurveillance (27–31).”
From The microbiome and human cancer (2021) · cites this paper as [31]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Self-citationMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Research works printed but not linked: 1
- 10.1111/j.1572-0241.2000.01860.x · doi:10.1111/j.1572-0241.2000.01860.x · Paper page
Cited by
Items 801–900 of 1,001
Yang, H., Chen, J., Li, J., Zhang, Z., Zhao, K., Yin, X., Wang, Z., Zhu, G., Yan, X., Jiang, Z., et al. (2024) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.10.014 · Cited by 14
Dai, H., Yang, H., Wang, R., Wang, X., & Zhang, X. (2025) · Nutrients · doi:10.3390/nu17091505 · Cited by 10
“Emerging evidence suggests that gut microbiota dysbiosis is not only associated with oncogenic effects and interference with the metabolism of cancer chemotherapy but also serves as a potential biomarker of cancer-treatment-related toxicity [21,22].”
Blanco, J. R., del Campo, R., Ortiz, J. A., Olmos, M. L., & Carnero, A. (2025) · Cells · doi:10.3390/cells14221813 · Cited by 14
“Garret [12] outlined three principal mechanisms by which microbes influence carcinogenesis: (1) regulation of host cell proliferation and death, (2) modulation of immunity, and (3) alteration of the metabolism of dietary constituents and host-derived factors.”
Tingting, Y., Xiaoling, Z., Zhang, Y., Luo, Y., Luo, Y., Xueqin, S., & Shikai, T. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1609889 · Cited by 10
“Studies have shown that the intratumoral microbiota can in fl uence tumorigenesis, progression and metastasis through multiple mechanisms, while possessing the dual properties of promoting and inhibiting cancer progression (Figure 1) (2, 5, 6, 8, 9).”
Examining the impact of the microbiome on cancer immunotherapy outcomes: A review
Ahlawat, A., Chauhan, S., Antil, I., Jha, S. K., & Huddar, V. G. (2025) · Ayush journal of integrative oncology. · doi:10.4103/ajio.ajio_42_25 · Cited by 20
Biodiversity and biogeography of the multi-kingdom cancer microbiome
Dohlman, A. B., Mjelle, R., Wood, H. M., Jiang, K., Shumate, A., Lee, I., Piccinno, G., Serna, G., Yakubu, A.-R., Nuciforo, P. G., et al. (2026) · Cell · doi:10.1016/j.cell.2026.04.015 · Cited by 15
Role of human microbiota in the development of colorectal cancer
Kochkina, S. O., Гордеев, С. С., & Mamedli, Z. Z. (2019) · Surgery and Oncology · doi:10.17650/2686-9594-2019-9-3-11-17 · Cited by 11
Role of Gut Microbiome and Enteric Bacteria in Gallbladder Cancer
Sharma, J., Huda, F., Naithani, M., Singh, S. K., Kumar, N., & Basu, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104404 · Cited by 12
The Role of Microorganisms in Appendiceal Pseudomyxoma Peritonei: A Review
Khamzina, Y., King, M. C., Nieroda, C. A., Merrell, D. S., Sardi, A., & Gushchin, V. (2022) · Current Oncology · doi:10.3390/curroncol29050289 · Cited by 9
“Several contributing mechanisms, including heightened inflammation, altered gene expression, and epigenetic effect were proposed [16].”
BackgroundJahić, M., & Cerovac, A. (2022) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4908169 · Cited by 15
Bahuguna, A., & Dubey, S. K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188956 · Cited by 11
Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes
Zhu, S., & Zhao, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1326627 · Cited by 13
“Data show that the microbiota may be associated with over one-fi fth of malignant tumors (Garrett, 2015).”
BackgroundSystematic review on the role of the gut microbiota in tumors and their treatment
Shi, Y., Li, X., & Zhang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1355387 · Cited by 14
“Moreover, these bacteria possess signi fi cant characteristics that augment the persistence of chronic in fl ammation, consequently fostering the progression and proliferation of tumors (21).”
BackgroundUnderstanding Immune Tolerance of Cancer: Re‐Purposing Insights from Fetal Allografts and Microbes
Barnet, M. B., Blinman, P. L., Cooper, W. A., Boyer, M. J., Kao, S., & Goodnow, C. C. (2018) · BioEssays · doi:10.1002/bies.201800050 · Cited by 11
Bose, D., Banerjee, S., Singh, R. K., Wise, L. M., & Robertson, E. S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03203-4 · Cited by 11
Geng, H., Dong, Z., Zhang, L., Yang, C. G., Li, T., Lin, Y., Ke, S., Xia, X., Zhang, Z., Zhao, G., et al. (2022) · Cancers · doi:10.3390/cancers14133276 · Cited by 14
“The microbiota is reported to be tightly associated with tumorigenesis and progression, which also serves as a key orchestrator of cancer therapy [14,15].”
BackgroundProspect of bacteria for tumor diagnosis and treatment
Xu, Y., Zhao, C., Ma, X., & Zhang, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121215 · Cited by 9
Impact of the gut microbiome on response and toxicity to chemotherapy in advanced esophageal cancer
Li, N., Gao, L., Ge, Y., Zhao, L., Wang, Y., & Bai, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32770 · Cited by 12
“Increasing evidence has demonstrated that gut microorganisms are associated with tumors [7].”
BackgroundThe role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy
Dean, N. J., d’Arienzo, P. D., Ibraheim, H., Lee, K. A., Olsson-Brown, A. C., Pinato, D. J., & Powell, N. (2024) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2024.101944 · Cited by 9
Plaza‐Díaz, J., Ruiz‐Ojeda, F. J., Plaza, B. L., Brandimonte‐Hernández, M., Álvarez‐Mercado, A. I., Arcos-Castellanos, L., Feliú, J., Hummel, T. R., Milla, S. P., & Gil, Á. (2024) · Cancers · doi:10.3390/cancers16193414 · Cited by 9
“There is still a need for further studies with a large number of patients and variables to be measured.”
BackgroundRenu, K. (2024) · Journal of Stomatology Oral and Maxillofacial Surgery · doi:10.1016/j.jormas.2024.102134 · Cited by 8
Fungal influence on immune cells and inflammatory responses in the tumor microenvironment (Review)
Zhang, J., Feng, Y., Li, D., & Shi, D. (2024) · Oncology Letters · doi:10.3892/ol.2024.14796 · Cited by 10
Intratumor microbiota and colorectal cancer: Comprehensive and lucid review
Zong, Z., Zeng, W., Li, Y., Wang, M., Cao, Y., Cheng, X., Jin, Z., Mao, S., & Zhu, X. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.07 · Cited by 9
Wang, Z., Mou, R., Jin, S., Wang, Q., Ju, Y., Sun, P., Xie, R., & Wang, K. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142341 · Cited by 9
RetractedLu, Y., Lan, R., Fan, Q., Tang, H., Hu, D., Zhang, S., Lin, X., Wang, R., Zhao, R., Sun, H., et al. (2025) · The ISME Journal · doi:10.1093/ismejo/wraf130 · Cited by 8
Pan, D., Bao, Y., Lu, X., Gu, Q., Zhang, Y., & Zheng, Y. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5655 · Cited by 11
Makkar, S. K., & Bishnupuri, K. S. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1676796 · Cited by 11
“Subsequent advances in sequencing technologies expanded this paradigm, revealing complex microbial communities—collectively termed microbiomes—as integral regulators of tumor initiation, progression, and response to treatments (Garrett, 2015).”
Nano Delivery Strategy Opens Effective Avenues for the Treatment of Colorectal Cancer
Wei, Q., Xu, Y., Zhang, T., Xu, S., Wang, H., Wang, Y., Xie, X., & Liang, X. (2026) · Medicine Bulletin · doi:10.1002/mdb2.70028 · Cited by 13
Association of oral microbiome and pancreatic cancer: a systematic review and meta-analysis
Yuan, M., Xu, Y. H., & Guo, Z. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221123980 · Cited by 10
Current advances in microbial-based cancer therapies
Shahbaz, A., Mahmood, T., Javed, M. U., & Abbasi, B. H. (2023) · Medical Oncology · doi:10.1007/s12032-023-02074-x · Cited by 9
“among the microbial species and the regression of tumors [14, 25].”
BackgroundBacterial Flagellum–Drug Nanoconjugates for Carrier‐Free Immunochemotherapy
Fu, Z., Wang, L., Guo, H., Lin, S., Huang, W., & Pang, Y. (2023) · Small · doi:10.1002/smll.202306303 · Cited by 11
Research progress on the microbiota in bladder cancer tumors
Lou, K., Chi, J., Wu, J., Ma, J., Liu, S., & Cui, Y. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1374944 · Cited by 10
“Escherichia coli produces the genotoxin colibactin, which causes mutagenic DNA damage through covalent DNA binding to a chemical moiety known to promote tumorigenesis (Garrett, 2015).”
BackgroundJabarin, A., Shtar, G., Feinshtein, V., Mazuz, E., Shapira, B., Ben‐Shabat, S., & Rokach, L. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae108 · Cited by 10
“More research is needed to fully understand the complex interactions between bacterial communities and cancer development [20].”
BackgroundImmunotherapy efficacy and toxicity: Reviewing the evidence behind patient implementable strategies
Verhaert, M., & Aspeslagh, S. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.114235 · Cited by 11
Roles of intralesional bacteria in the initiation and progression of oral squamous cell carcinoma
Luo, Z., Lv, S., Lou, F., Yan, L., Xu, J., Kang, N., Dong, Y., & Jin, X. (2024) · Cancer Medicine · doi:10.1002/cam4.70209 · Cited by 10
“9 In contrast to the oral and gut microbiota, intralesional microbiota has received less attention in the past due to its minimal biomass.”
BackgroundZhou, Q., Zhou, L., Chen, X., Chen, Q., & Hao, L. (2024) · Cancer Reports · doi:10.1002/cnr2.70063 · Cited by 13
“Similarly, F.n recruits MDSCs and promotes the JAK–STAT signaling pathway expression, leading to the release of a large number of chemokines and interleukins, which ultimately induce an inflammatory response [62].”
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development
Todorović, N., Martinelli, S., Nannini, G., Weiskirchen, R., & Amedei, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413510 · Cited by 9
Oral Microbiome Signatures as Potential Biomarkers for Gastric Cancer Risk Assessment
In, H., Perati, S. R., Usyk, M., Yang, J. T., Sarkar, S., Rana, B., Wang, F., Oh, A., Adams, A., Diggs, L. P., et al. (2024) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2024.101933 · Cited by 9
Tracking Pathogen Infections by Time‐Resolved Chemical Proteomics
Zhang, Y., Kao, D., Gu, B., Bomjan, R., Srivastava, M., Lu, H., Zhou, D., & Tao, W. A. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201911078 · Cited by 8
[Correlation between Gut Microbiota and Lung Cancer].
Teng, J., Zhao, Y.-F., Jiang, Y., Wang, Q., & Zhang, Y. (2020) · PubMed Central · doi:10.3779/j.issn.1009-3419.2020.101.39 · Cited by 8
Li, M., Shao, D., Zhou, J., Gu, J., Qin, J., Li, X., Hao, C., & Wei, W. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00645-21 · Cited by 9
“Once the microbiota becomes unbalanced, the microenvironment may change, leading to disease (4).”
BackgroundHuang, W., Tang, M., Chen, Y., Zhang, T., Hong, T., Lv, G., Lv, G., Ouyang, Z.-H., Ouyang, Z.-H., & Zou, M. (2022) · Cancers · doi:10.3390/cancers14092053 · Cited by 12
The Gut Microbiome in Colorectal Cancer
Piawah, S., Walker, E. J., Blarigan, E. L. V., & Atreya, C. E. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.03.001 · Cited by 9
Wang, W., Xu, Y., Wang, X., Chu, Y., Zhang, H., Zhou, L., Zhu, H., Ji, L., Kuai, R., Zhou, F., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.929092 · Cited by 9
“Integration Analysis Among Intestinal Microbiota Community, Colonic Lipid Metabolites, and Transcriptomics to Construct Anti-Inflammatory and AntiTumorigenic Transcriptional Networks Since the development of CRC is influenced by the interaction of the tumormicroenvironment (TME) and the intestinal microbiota (34).”
BackgroundFecal Microbes Associated with the Outcomes After Esophagectomy in Patients with Esophageal Cancer
Maruyama, S., Okamura, A., Kanie, Y., Sakamoto, K., Fujiwara, D., Kanamori, J., Imamura, Y., Takeda, K., & Watanabe, M. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12166-z · Cited by 9
The Influence of the Gut Microbiome in Paediatric Cancer Origin and Treatment
Sági, V., Makra, N., Csoszánszki, N., Decmann, Á., Szabó, D., & Garami, M. (2022) · Antibiotics · doi:10.3390/antibiotics11111521 · Cited by 12
“Toxic metabolites produced by the microbiota can also affect the immune system [14].”
BackgroundButters, C. T., Thursky, K., Hanna, D. T., Cole, T. S., Davidson, A. J., Buttery, J. P., & Haeusler, G. M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2171987 · Cited by 8
Antibodies to oral pathobionts and colon cancer risk in the CLUE I cohort study
Debertin, J. G., Teles, F., Martin, L. M., Lu, J., Koestler, D. C., Kelsey, K. T., Beck, J. D., Platz, E. A., & Michaud, D. S. (2023) · International Journal of Cancer · doi:10.1002/ijc.34527 · Cited by 8
Rangamuwa, K., Aloe, C. A., Christie, M., Asselin-Labat, M.-L., Batey, D., Irving, L., John, T., Bozinovski, S., Leong, T. L., & Steinfort, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1129195 · Cited by 15
Innovative Therapy, Monoclonal Antibodies and Beyond
Nicola, M. D., Apétoh, L., Bellone, M., Colombo, M. P., Dotti, G., Ferrone, S., Muscolini, M., Hiscott, J. B., Anichini, A., Pupa, S. M., et al. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.10.002 · Cited by 8
Predictive Values of Colon Microbiota in the Treatment Response to Colorectal Cancer
Ros, J. G., Ramos-Arenas, V., & Conesa‐Zamora, P. (2020) · Pharmacogenomics · doi:10.2217/pgs-2020-0044 · Cited by 9
Deng, X., Chen, X., Luo, Y., Que, J., & Chen, L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1202454 · Cited by 8
“The shifts in microbiota community structure might contribute to carcinogenesis and affect anti-cancer therapies through multiple biological pathways, such as immune, metabolism and signal transduction (Garrett, 2015).”
BackgroundWu, Y., Shen, N., Hope, C., Noh, H. I., Richardson, B. N., Swartz, M. C., & Bai, J. (2017) · Beneficial Microbes · doi:10.1163/18762891-bja00026 · Cited by 10
Environmental DNA and RNA Metabarcoding: Advancing Insights in Cancer Research
Ogidi, O. I., Christopher, E., & Orlu, H. A. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-2165-3.ch007 · Cited by 7
Fan, Y., Gu, X., Yang, H., Chen, Y., Fang, C., Deng, H., & Dai, L. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00376-2 · Cited by 10
Bacterial contributions to cancer development: mechanisms, dysbiosis, and cross-cancer associations
Ramadan, Y. N., Alatawi, M. N., Albalawi, A. S., & Hetta, H. F. (2026) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00722-7 · Cited by 13
“Furthermore, the complex networks between the microbiome and the host are represented by bidirectional crosstalk and several studies indicate that the development of various cancer types is influenced by microbiome dysbiosis [6, 18, 19], as summarized in Table 1.”
O’Connell, C. P., Berndt, S. I., Chudy‐Onwugaje, K., Kunzmann, A. T., Huang, W., Barry, K. H., & Loftfield, E. (2026) · Cancer · doi:10.1002/cncr.70201 · Cited by 11
“43,44 As mentioned above, there is also some evidence that moderate alcohol intake may reduce inflammation and lower DNA damage.”
Bachir, A., Altaie, A. M., Bendardaf, R., Talaat, I. M., & Hamoudi, R. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1795882 · Cited by 9
“Recent research has shown that dysbiosis contributes to chronic inflammation, DNA damage, epigenetic modifications, and immune evasion, highlighting the microbiota as an active participant in CRC pathogenesis rather than a passive bystander (Rubinstein et al., 2013; Clay et al., 2022; Garrett, 2015).”
Pekel, S., Karcher, N., Essex, M., Springer, F., Romano, S., Ducarmon, Q. R., Schudoma, C., Larralde, M., Lupatin, A., Zeißig, S., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.030 · Cited by 11
The complex immunological role of Helicobacter in modulating cancer
Hand, T. W., & Overacre-Delgoffe, A. E. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.08.002 · Cited by 10
Lung microbiome in children with hematological malignancies and lower respiratory tract infections
Zhang, Y., Ning, H., Zheng, W., Liu, J., Li, F., & Chen, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.932709 · Cited by 7
Condic, M., Neidhöfer, C., Ralser, D. J., Wetzig, N., Thiele, R., Sieber, M., Otten, L. A., Warwas, L. K., Hoerauf, A. M., Mustea, A., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04599-0 · Cited by 9
“…Hospital Bonn, Bonn, Germany 2 Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany 3 Institute for Functional Gene Analytics, Bonn-Rhein-Sieg University of Applied Sciences, Sankt Augustin, Germany 1 3 cervico-vaginal microbiome (Garrett 2015).”
Clinical potential of microbiota in thyroid cancer therapy
Xie, Z., Zhou, J., Zhang, X., & Li, Z. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166971 · Cited by 7
Liu, Y., Zhang, J., Chen, H., Zhang, W., Ainiwaer, A., Mao, S., Yao, X., Xu, T., & Yang, Y. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1302870 · Cited by 10
“In recent years, with the understanding of microorganisms, it has been found that the contribution of microorganisms to human malignant tumors is as high as 20% (Garrett, 2015).”
BackgroundThe value of intratumoral microbiota in the diagnosis and prognosis of tumors
Zhou, L., Zhang, W., Fan, S., Wang, D., & Tang, D. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3999 · Cited by 7
Relevance of harmful intratumoral microbiota in cancer progression and its clinical application
Yu, R., Wang, S., & Han, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117238 · Cited by 9
Intratumoral microbiota: an emerging force in diagnosing and treating hepatocellular carcinoma
Liu, H., Zhang, J., Rao, Y., Jin, S., Zhang, C., & Bai, D. (2024) · Medical Oncology · doi:10.1007/s12032-024-02545-9 · Cited by 10
“Intratumoral microbes are thought to influence tumor progression primarily by causing DNA damage, activation of oncogenic pathways and regulation of the immune system in the microenvironment [13, 45–47].”
Liang, P., Chen, Q., Chen, X., Zhang, X., Xiao, Y., Liang, G., Liu, M., He, J., Liang, W., Liang, Y., et al. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-24-393 · Cited by 8
“Recent studies have linked commensal microbiota to activation of oncogenic signaling pathways (44,45) , or promotion on tumor progression (46) .”
Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives
Lombardo, C., Fazio, R., Sinagra, M., Gattuso, G., Longo, F., Lombardo, C., Salmeri, M., Zanghì, G., & Loreto, C. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14111083 · Cited by 8
Study of Microbiota Associated to Early Tumors Can Shed Light on Colon Carcinogenesis
Aspesi, A., Vecchia, M. L., Sala, G., Ghelardi, E., & Dianzani, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413308 · Cited by 8
Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma
Song, Y., Tian, S., Li, Z., Miao, J., Wu, M., Xu, T., Wu, X., Qiao, J., Zhang, X., Zhao, H., et al. (2025) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s496964 · Cited by 7
“52,53 Nejman et al demonstrated that the intratumoral microbiota is tumor-specific, which may imply that the metabolic pathways involved in microorganisms in different environments will have different effects on tumor cells.”
Periodontitis Exacerbates Colorectal Cancer by Altering Gut Microbiota–Derived Metabolomics in Mice
Wang, X., Li, Z., Zhou, H., Liu, Q., Zhang, X., & Hu, F. (2025) · Journal of Periodontal Research · doi:10.1111/jre.13380 · Cited by 10
Huang, W., Jiang, T., He, J., Ruan, J., Wu, B., Tao, R., Xu, P., Wang, Y., Chen, R., Wang, H., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10471-z · Cited by 9
Yao, Y., Liu, W. C., Li, J., Zhou, M., Qu, C., & Wang, K. (2021) · Medical Oncology · doi:10.1007/s12032-021-01552-4 · Cited by 8
Hepatocellular Cancer and Gut Microbiome: Time to Untie Gordian’s Knot
Aygün, C., & Tozun, N. A. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00736-5 · Cited by 7
“Genetic features of the host, environmental factors, and microbiota altogether can be implicated in the development of HCC [18].”
BackgroundSalem, M. B., Aiche, G., Haddab, Y., Rubbert, L., & Renaud, P. (2022) · Journal of Medical Devices · doi:10.1115/1.4055250 · Cited by 8
Dogra, S., Oneto, C., Sherman, A., Varughese, R., Yuen, A., Sherman, I., Cohen, A., Luo, Y., & Chen, L. A. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001778 · Cited by 7
Interaction of microbiome and immunity in tumorigenesis and clinical treatment
Yu, Y., & Zhong, W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113894 · Cited by 10
Treeriya, R., Ho, P. N., Titapun, A., Klanrit, P., Suksawat, M., Kulthawatsiri, T., Sirirattanakul, S., Loilome, W., Namwat, N., Wangwiwatsin, A., et al. (2023) · PeerJ · doi:10.7717/peerj.15386 · Cited by 7
“This metabolic interaction between host-gut microbiota has been reported to be relevant with its implication in cancer susceptibility of liver cancer, colorectal cancer, gastric cancer, and hepatobiliary cancers (Garrett, 2015).”
BackgroundMicrobiome, a new dimension in cancer research.
Neto, A. G., Bradshaw, A.-D., & Pei, Z. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.08.07 · Cited by 8
Resident Microbiome of Kidney Tumors
Kovaleva, O. V., Алексеевна, П. П., & Gratchev, A. N. (2024) · Oncology Reviews · doi:10.3389/or.2024.1393664 · Cited by 6
“The International Agency for Research on Cancer (IARC) identi fi es 10 microorganisms whose role in carcinogenesis has been established and proven [3].”
BackgroundLu, W., Aihaiti, A., Abudukeranmu, P., Liu, Y., & Gao, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05320-6 · Cited by 9
“As research progresses, the potential of intratumoral bacteria in digestive system cancer development is increasingly recognised, paving the way for innovative approaches to digestive system cancer therapy (Table 1) [30–32].”
BackgroundLi, L., XinSheng, Z., Xiang, H., Liu, Z., Liu, L., XiuMing, L., Li, Y., Chen, J., KeMing, Z., HongChi, W., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1424039 · Cited by 6
“Evidence links it to various cancers (59, 60), potentially offering novel cancer therapies targeting the gut microbiome.”
BackgroundAlhamlan, F. S., Al-Badawi, I. A., Al-Qahtani, A. A., Awartani, K. A., Obeid, D. A., & Tulbah, A. M. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1489942 · Cited by 9
“…insights into the mechanisms by which microorganisms contribute to the initiation and progression of malignancies, potentially leading to the development of targeted strategies for the early detection, prevention, and therapeutic intervention of cancer (Łaniewski et al., 2020; Garrett, 2015).”
Khan, Z. A., Song, S., Xu, H., Ahmad, M., Wang, A., Abdullah, A., Jiang, L., & Ding, X. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107471 · Cited by 7
Gut-thyroid axis and emerging role of probiotics in thyroid disorders
Parveen, N., Chittawar, S., & Khandelwal, D. (2025) · Thyroid Research and Practice · doi:10.4103/trp.trp_12_24 · Cited by 10
Ghogare, S. S., & Pathan, E. K. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02483-z · Cited by 8
Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications
Yang, S.-F., Chen, X., & Pan, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1598009 · Cited by 6
“Its role in diseases such as cancer, liver disease, obesity, and neuropsychiatric disorders has been increasingly recognized (Garrett, 2015; Hand et al., 2016).”
Identification and Evaluation of the Urinary Microbiota Associated With Bladder Cancer
Li, N., Wang, L., Yang, Q., Li, F., Shi, Z., Feng, X., Zhang, L., Li, X., Jin, X., Zhu, S., et al. (2025) · Cancer Innovation · doi:10.1002/cai2.70012 · Cited by 8
“Some pathogenic microorganisms can damage host DNA through gene toxins, such as colicin produced by certain Escherichia coli strains, or indirectly by producing reactive oxygen species [15].”
Xue, J., Liu, Q., Xu, D., Pang, H., & Shi, Y. (2025) · BMC Microbiology · doi:10.1186/s12866-025-03877-w · Cited by 7
Bacteria-assisted metal antitumor immunotherapy
Guo, J., Liang, J., Chen, Z., Pan, Y., He, Y., & Chao, H. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216938 · Cited by 6
Intratumoral microbial heterogeneity in HCC reveals a potential therapeutic target
Li, L., Wang, M., Jiang, Z., Yi, C., & Yi, Y. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101538 · Cited by 7
“4,5 Advances in microbial detection technologies have identified the intratumoral microbiota in multiple cancers, such as breast, lung, ovarian, pancreatic cancers, melanoma, bone tumors, and brain tumors.”
Panyod, S., Wu, W., Lee, Y.-P., Lin, T., Kuo, P.-C., Yen, C.-S., Chen, Y., Chuang, H.-L., Lo, I., Yang, Y.-T., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.015 · Cited by 10
Recent Advances in Nanomedicine for Modulating Intratumoral Bacteria in Cancer Therapy
Zhang, Y., Zhang, H., Xu, J., Xu, Z., Lou, J., Zheng, Q., Yuan, S., Zhu, L., & Xu, X. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00677 · Cited by 8
The Science behind Probiotics: Exploring their Mechanisms and Therapeutic Potential
Entezami, A., & Zarrini, G. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10820-y · Cited by 9
“Recent studies have shown a relation between the composition and function of the gut microbiota and cancer, espe - cially gastrointestinal cancer [ 159].”
RETRACTED: Understanding microbiota-driven oncogenesis: The role of metabolites in tumorigenesis
Ullah, S., Wu, C., Zou, X., Zhong, Y., Ahmad, A., Jan, A. U., Cong, Y., Chen, Y., & Li, L. (2025) · iScience · doi:10.1016/j.isci.2025.113945 · Cited by 8
“…of the immune system; and (3) changing the metabolism of endogenous factors, dietary elements, and pharmaceuticals, as described in Figure 3B. 71 These findings demonstrate strong associations between dysbiosis and CRC. Emerging studies suggest that these links are more nuanced and…”
RetractedIntratumoral microbiome composition and its role in tumor recurrence in primary liver cancer
Liu, W., Kuo, H., Tsai, H., Lin, Y., Ruan, J., Lee, C., Sun, H.-Y., Wu, I., & Chang, T. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.11.031 · Cited by 6
Su, S., Bu, Q., Bai, X., Huang, Y., Wang, F., Hong, J., Fang, J., Wu, S., & Sheng, C. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106586 · Cited by 6
Identification of Merkel Cell Polyomavirus from a Patient with Acute Myeloid Leukemia
Song, Y., & Gyarmati, P. (2017) · Genome Announcements · doi:10.1128/genomea.01241-16 · Cited by 6
Probiotics for Management of Gastrointestinal Cancers
Rai, N., Singh, S. P., Keshri, P. K., Barik, S., Kamble, S. C., Singh, S. K., Kumar, R., Mishra, P., Kotiya, D., & Gautam, V. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_9 · Cited by 8
Metadata
- Authors
- Garrett, W. S.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- ORCID
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2015-04-03
- Volume
- 348
- Issue
- 6230
- Pages
- 80-86
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5535753
- OpenAlex
- W2073924079
- Cited by
- 1,404
- References
- 119
- Citations by year
- 2026: 145 · 2025: 169 · 2024: 169 · 2023: 151 · 2022: 162 · 2021: 141 · 2020: 127 · 2019: 106 · 2018: 77 · 2017: 68 · 2016: 58 · 2015: 29
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01CA154426)
- Burroughs Wellcome Career in Medical Sciences Award
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- gut microbiota, cancer susceptibility, carcinogenesis, host-microbe interactions, cancer therapy response, cancer diagnosis
- MeSH terms
- Humans, Immunotherapy, Neoplasms, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.